Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
Risa Yamada1,2,3, Takeshi Fujii2,4, Kotaro Hattori5,6, Hiroaki Hori7, Ryo Matsumura5, Tomoko Kurashimo4,5, Naoko Ishihara4,5, Sumiko Yoshida4,5,8, Tomiki Sumiyoshi1,2,4, Hiroshi Kunugi5,6,9
1Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 2Department of Psychiatry, National Center Hospital of Neurology and Psychiatry, 3Department of Psychiatry, Jikei University School of Medicine, 4Mood Disorder Center for Advanced Therapy, National Center Hospital of Neurology and Psychiatry, 5Medical Genome Center, National Center of Neurology and Psychiatry, 6Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 7Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, 8Department of Psychiatric Rehabilitation, National Center Hospital of Neurology and Psychiatry, 9Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
Correspondence to: Hiroshi Kunugi
Department of Psychiatry, Teikyo University School of Medicine, 2-11-1 Kaga Itabashi-ku, Tokyo 173-8605, Japan
E-mail: hkunugi@med.teikyo-u.ac.jp
ORCID: https://orcid.org/0000-0002-7209-3790
Received: December 16, 2021; Revised: February 10, 2022; Accepted: February 11, 2022; Published online: May 30, 2023.
© The Korean College of Neuropsychopharmacology. All rights reserved.

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Objective: This study aimed to determine if the discrepancy between depression severity rated by clinicians and that reported by patients depends on key behavioral/psychological features in patients with mood disorders.
Methods: Participants included 100 patients with mood disorders. First, we examined correlations and regressions between scores on the Hamilton Depression Rating Scale (HAMD) and Beck Depression Inventory (BDI). Second, we divided the participants into those who provided 1) greater ratings for the BDI compared with the HAMD (BDI relative- overrating, BO) group, 2) comparable ratings for the BDI and HAMD (BDI relatively concordant, BC) group, or 3) less ratings for the BDI (BDI relative-underrating, BU) group. Adverse childhood experiences, autistic-like traits, and coping styles were evaluated with a six-item short version of the Childhood Trauma Questionnaire (CTQ-6), the Social Responsiveness Scale for Adults (SRS-A), and the Ways of Coping Checklist (WCCL), respectively.
Results: A significant correlation was found between HAMD and BDI scores. Total and emotional abuse subscale scores from the CTQ-6, and the self-blame subscale scores from the WCCL were significantly higher for the BO group compared with the BU group. The BO group also elicited significantly higher SRS-A total scores than did the other groups.
Conclusion: These findings suggest that patients with adverse emotional experiences, autistic-like traits, and self-blame coping styles perceive greater distress than that evaluated objectively by clinicians. The results indicate the need for inclusion of subjective assessments to effectively evaluate depressive symptoms in patients deemed to have these psycho- behavioral concerns.
Keywords: Depression; Self report; Adverse childhood experiences; Coping behavior; Mood disorders; Autistic disorder
INTRODUCTION

Patients with major depressive disorder (MDD) exhibit depressive symptoms, such as depressed mood, anhedonia, anxiety, changes in appetite, sleep disturbance, feelings of guilt, and suicidal ideation [1,2]. In addition to these symptoms common to MDD, bipolar disorder (BD) is characterized by hyperactivity, mood swings, and risk- taking behavior and/or the history of them [1,3]. Recurrence is common in both diseases, and negatively influences social functioning [4-6].

To evaluate depression severity, several clinician-rated assessment scales (CRs) have been used, such as the Hamilton Depression Rating Scale (HAMD) [7,8] and the Montgomery−Åsberg Depression Rating Scale [9]. There are also self-report questionnaires (SRs), such as the Quick Inventory of Depressive Symptomatology-Self Report [10] and the Beck Depression Inventory (BDI) [11], which have been validated. Combined use of CRs and SRs to measure severity of symptoms may facilitate measurement-based care, an essential component of evidence-based medicine [12], although the set of assessment may often be difficult in daily clinical settings with time-constraint.

Correlations between CRs and SRs for depression severity vary from 0.2 to 0.8 [13], indicating discrepancy in several cases. Recently, the importance of “patient-centered care” has increasingly been recognized [14,15]. In this framework, patients are encouraged to be actively involved in their own treatment decisions rather than simply following the direction of physicians. Accordingly, more emphasis is placed on assessments with SRs when evaluating treatment outcome. At the same time, it would be meaningful to identify factors that relate to the discrepancy between CRs and SRs. Previous studies suggest that demographic and personality factors are associated with such discordance regarding depression severity in MD patients. Specifically, the difference between data from CRs and SRs is eminent in patients with mild-to-moderate depression [16-18]. Furthermore, depressed patients who over-reported the severity tended to show personality traits of low extraversion [19,20], agreeableness [20,21], openness to experience [22], and self-esteem [16], as well as high neuroticism [19,20]. In addition, the discrepancy between CRs and SRs has been reported to be associated with worse response to treatments and cognitive distortions in BD [23].

It is important to examine which clinical factors are associated with the discrepancy between CRs and SRs in mood disorders. Such discordance is hypothesized to be affected by psychological characteristics related to depressive symptoms. In the present study, we aimed to examine the possible associations of the SRs/CRs difference with adverse childhood experiences, autistic-like traits, and coping styles in mood disorders.

METHODS

Participants comprised 100 patients with MDD (n = 60) or BD (n = 40) who had received medical examinations from October 2017 to February 2020 in the outpatient clinic of the Mood Disorder Center for Advanced Therapy at the National Center of Neurology and Psychiatry (NCNP) Hospital, Japan. We included depressed patients with BD as well as those with MDD, which enabled us to find more general tendency in depressed patients irrespective of diagnosis, and enlarged the sample size to minimize the possibility of type II error. The study procedures were explained, and informed consent was obtained from patients (agreement rate: 76%). Study exclusions consisted of the following criteria: (1) being 16 years old or younger, or (2) the primary diagnosis not being of MDD or BD. The participants were screened for Axis I psychiatric disorders by a trained research psychologist using the Japanese version of the Mini-International Neuropsychiatric Interview [24]. The diagnosis was made according to the Diagnostic and Statistical Manual of Mental Disorders 4th Edition criteria [25], based on the information from the Mini-International Neuropsychiatric Interview, additional unstructured interviews, and medical records. This study was approved by the ethics committee of the NCNP, Tokyo, Japan (A2021-081).

Clinical and Psychological Assessments

Depression severity was evaluated by trained research psychologists by using the GRID Hamilton Depression Rating Scale 17-items (HAMD-17) [7,8], while manic symptoms were measured by the Young Mania Rating Scale [26]. Subjectively perceived depressive symptoms were assessed using the Japanese version of the BDI. The BDI was developed by Beck et al. [11] as a screening tool to calculate the severity of depressive symptoms using 21 items, each of which is rated from 0 to 3, with a total score range of 0−63. The Japanese version of the BDI is a reliable and valid tool for measuring the severity of depressive symptoms [27].

A six-item short version of the Childhood Trauma Questionnaire (CTQ-6) [28] was used to self-evaluate adverse childhood experiences. Its six items are grouped into three factors: physical abuse, emotional abuse, and emotional neglect. Items are rated using a five-point Likert scale ranging from 1, “never true,” to 5, “very often true”.

The Japanese version of the Social Responsiveness Scale for Adults (SRS-A) [29-31] was used as a reliable and valid tool for measuring autistic-like traits. It evaluates self-reported autistic-like traits of respondents via 63 items that are grouped into five categories; social awareness, social cognition, social communication, social motivation, and restricted interests. Items are rated using a four-point Likert scale ranging from 0, “not true,” to 3, “almost always true”.

The Japanese version of the Ways of Coping Checklist (WCCL) [32,33], a self-report instrument, was used to evaluate coping styles. Its 47 items are grouped into six coping styles; problem-solving, positive reappraisal, social support, self-blame, wishful thinking, and escape-avoidance. Each item is rated using a four-point Likert scale ranging from 0, “not used,” to 3, “regularly used”.

Patient Categories by Discrepancies between Patient- and Clinician-rated Scales

This study aimed to examine the possible associations of the SRs/CRs difference with psychological characteristics related to depressive symptoms. The patients were classified into three groups according to a previous study [34], based on distance from a point to a line in Euclidean geometry [35]. Pearson correlations were calculated between the HAMD-17 and BDI scores, and their regression line was determined. The distance from the regression line to the BDI scores was measured and the magnitudes of the distances were divided into quartiles. The top 25% consisted of persons with BDI scores higher than the predicted value (BDI relative-overrating group, BO group), the middle 25−75% consisted of those with BDI scores similar to the predicted value (BDI relatively concordant group, BC group), and bottom 75−100% consisted of those with lower BDI scores than the predicted value (BDI relative-underrating group, BU group).

Statistical Analysis

Statistical analyses were performed using SPSS Version 25.0 (SPSS Japan). Continuous variables were compared among the BO, BC, and BU groups using Kruskal−Wallis test for mean education level, chlorpromazine-equivalent dose, HAMD-17, BDI, YMRS, SRS-A, WCCL, and CTQ-6 scores. Between-group differences were examined by pairwise multiple comparisons using rank sums, as proposed by Dunn [36]. Pairwise multiple comparisons were conducted with Bonferroni correction. Categorical variables were compared by chi-square test.

RESULTS

Correlation and Regression Analyses between HAMD and BDI Scores

HAMD scores were correlated significantly with BDI scores (Pearson’s r= 0.624, p < 0.001) (Fig. 1). Regression analysis by least squares method was performed with HAMD scores as the independent variable and BDI scores as the dependent variable, which yielded the equation of; BDI-II = 1.1 × HAMD-17 + 7.89 (R2 = 0.389).

Analyses of Clinical Variables

Demographic and clinical characteristics of the participants are shown in Table 1. The median HAMD score was 13.0, whereas the median for BDI scores was 21.0. The percentage of comorbid psychiatric disorders with agoraphobia, social anxiety disorder, panic disorder, alcohol use disorders, and obsessive-compulsive disorder were 13.0%, 10.0%, 9.0%, 6.0%, and 4.0%, respectively.

Demographic and clinical characteristics of the participants allocated to the BO, BC, or BU groups are shown in Table 1. Total BDI scores were significantly different among the three groups, while their HAMD scores and other clinical variables did not significantly differ. In addition, there were no significant between-group differences in demographic and clinical characteristics.

Analyses of Psychological Measures

Data on psychological measures are shown in Table 2. Total CTQ-6 scores and emotional abuse subscale scores were significantly higher for the BO group compared to the BU group. By contrast, physical abuse and emotional neglect scores were not significantly different among the three groups.

SRS-A total scores were significantly higher for the BO group compared to the BC or BU group. The same applied to SRS-A subscales scores of social cognition, social communication, social motivation, and autistic mannerisms. On the other hand, social awareness scores were not significantly different among the three groups.

Among the six WCCL subscales, self-blame scores were significantly higher in the BO group than in the BC and BU groups. Wishful thinking and escape-avoidance scores were significantly higher in the BC group than in the BU group. By contrast, subscale scores on coping strategies of problem-solving, positive reappraisal, and social support did not significantly differ among the three groups.

DISCUSSION

To our knowledge, this is the first study to demonstrate the contribution of adverse childhood experiences, autistic-like traits, and coping styles to the difference between severity of depressive symptoms reported subjectively (with BDI) and that measured objectively (with HAMD) in patients with mood disorders. We also confirmed the correlation between BDI and HAMD scores in these patients, as reported in previous studies [37,38].

Our results indicating discordant data between the clinician-rated scale and self-report questionnaires suggest that caution is needed when assuming subjective symptoms based solely on objective observations. That is, clinician-rated scales may not effectively represent the actual distress experienced by some patients with mood disorders. These considerations suggest that the use of both SR and CR scales is desirable especially when emotional abuse experiences, autistic symptoms, and/or maladjusted coping styles are indicated through family history, history of present illness, and examination scenes.

Experience of emotional abuse was significantly more frequent in the BO group than in the BU group, suggesting negative influence of adverse childhood experiences on inner distress. Experiences of emotional abuse have been indicated to be associated with depressive symptoms in adulthood [39,40]. The current observations extend the findings from these previous studies by suggesting the link between emotional abuse and the dissociation between subjective and objective data on depressive symptoms. Also, our findings may be consistent with a greater increase in depressive symptoms in people who experienced emotional abuse compared to those who did not, when confronted with current depression-inducing stressors, such as interpersonal conflicts or academic/vocational failure [41]. Possibly, experiences of emotional abuse in childhood may enhance sensitivity to stressors, as manifested by the exaggerated subjective distress in patients with mood disorders.

Autistic-like traits (i.e., impaired social communication and social motivation, autistic mannerisms, etc.), as measured by the SRS-A, were more pronounced in patients who reported relatively severe subjective depression (BO group) compared to those who do not (BC and BU groups). In our previous study [42], SRS-A scores were associated with objective depressive symptoms, as evaluated by the HAMD, in patients with MDD. These findings suggest subjective, rather than objective, distress should be a major concern for clinicians who take care of people with autistic traits. In contrast, the BU group (patients with relatively less subjective symptoms) elicited lower SRS-A scores than the BO group, consistent with an association between under estimation of one’s depressive states and extroversion (i.e., sociable, having interests/concerns toward the outside world), as previously shown [19].

Patients with relatively severe subjective depressive symptoms (BO group) elicited higher scores for self-blame as evaluated by the WCCL, than those in the other groups (Table 2). This finding may be partially consistent with Hori et al. [43] who observed that emotion-focused coping is frequently used by patients with MDD. In agreement with the present results, exaggerated self-estimation of depressive states has been associated with cardinal factors for stress coping, such as cognitive distortions [23], as well as high neuroticism and low extraversion [19,20]. Specifi-cally, neuroticism has been reported to be moderately correlated with emotion-focused coping, such as self-blame in patients with depression [44]. These considerations may help identify patients with depressive symptoms who might benefit from psycho-education for coping strategies.

Limitations

This study has a few limitations that should be considered. First, patients in our study presented relatively milder symptoms (Table 1), with a relatively young median age, which may limit the generalizability of the results. Second, most patients were treated with antidepressant drugs following their first contact with psychiatric services; potential pharmacological effects were not considered. Further research with patients who have not been prescribed with antidepressants is warranted. Third, the relatively small sample size of this study was subject to type II errors. Fourth, this study did not include subjective measures of manic symptoms, unlike in the case for depression severity. Future research should determine the present or absence of discrepancy between subjective and objective manic symptoms. Finally, this study did not include objective measures of adverse childhood experience, autistic traits, coping style, unlike the case for depression severity. Future research should aim to investigate the presence or absence of discrepancy between subjective and objective data for these psychosocial aspects.

Conclusions

The results of the present study suggest that patients with mood disorders who express self-blame coping style, autistic-like traits, and/or adverse emotional experience perceive greater distress than that evaluated objectively by clinicians. Our data also indicate the need for inclusion of subjective assessments to effectively evaluate depressive symptoms in patients deemed to have the above psycho-behavioral problems.

Acknowledgments

Evaluation with the M.I.N.I. and the data were provided by NCNP biobank.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING

This work was supported by the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development, AMED (Grant number: 20dm0107100h0005) (Hiroshi Kunugi), Intramural Research Grants for Neurological and Psychiatric Disorders (Grant number: 30-1) (Hiroshi Kunugi) and (Grant number: 3-1) (Tomiki Sumiyoshi) from the National Center of Neurology and Psychiatry, and Japan Health Research Promotion Bureau Grants (Grant number: 2021-B-01) (Tomiki Sumiyoshi).

Author Contributions

Conceptualization: Hiroshi Kunugi, Risa Yamada. Trans-lated questionnaire English into Japanese (CTQ-6): Hiroaki Hori. Funding: Hiroshi Kunugi, Tomiki Sumiyoshi. Data acquisition: Tomiki Sumiyoshi, Sumiko Yoshida, Takeshi Fujii, Kotaro Hattori, Risa Yamada, Naoko Ishihara, Tomoko Kurashimo, Hiroshi Kunugi. Formal analysis: Risa Yamada, Ryo Matsumura. Writing−original draft: Risa Yamada. Super-vision: Hiroshi Kunugi, Tomiki Sumiyoshi, Hiroaki Hori, Takeshi Fujii. All authors have read and approved the revised manuscript.

Figures
Fig. 1. Correlation and regression analysis between HAMD and BDI scores. HAMD, Hamilton Depression Rating Scale; BDI, Beck Depression Inventory.
Tables

Comparison of demographic and clinical characteristics between participants among BDI-based groups

Variables Total (n = 100) BO group (n = 25) BC group (n = 50) BU group (n = 25) Statistical comparison

Statistic pvalue
Sex χ2 (2,98) = 2.564 0.277
Male 52 (52.0) 11 (44.0) 30 (60.0) 11 (44.0)
Female 48 (48.0) 14 (56.0) 20 (40.0) 14 (56.0)
Age 33.0 (24−46) 30.0 (24.0−38.5) 31.5 (22.75−46.75) 39.0 (25.5−53.0) H = 4.228 0.121
Education years 15.5 (12.0−16.0) 15.0 (12.0−16.0) 15 (12.0−16.0) 16.0 (12.0−16.0) H = 0.562 0.755
Age of onset 23 (18.25−33.0) 23.0 (18.5−28.5) 22.0 (18.0−34.25) 29.0 (20.0−36.0) H = 2.480 0.289
Suicide attempt 22 (22.0) 7 (28.0) 12 (24.0) 3 (12.0) χ2 (2,98) = 2.098 0.350
Psychiatric disorders χ2 (2,98) = 2.000 0.368
Major depressive disorder 60 (60.0) 14 (56.0) 28 (56.0) 18 (72.0)
Bipolar disorder 40 (40.0) 11 (44.0) 22 (44.0) 7 (28.0)
HAMD-17 13.0 (9−18.75) 15.0 (11.0−21.0) 12.0 (8.75−17.25) 13.0 (7.00−20.0) H = 3.032 0.220
BDI 21.0 (16.0−29.75) 35.0 (29.0−43.0) 20.5 (16.75−26.0) 11.0 (4.00−19.0) H = 54.37 < 0.001*
YMRS 0.0 (0.00−2.00) 0.0 (0.00−2.00) 0.0 (0.00−2.00) 1.0 (0.00−3.00) H = 0.695 0.707
Equivalent dose (mg/d)
Antipsychotics 0.00 (0.00−43.9) 0.00 (0.00−87.9) 0.00 (0.00−37.6) 12.5 (0.00−50.0) H = 1.279 0.527
Antidepressant 15.7 (0.00−150.0) 65.0 (0.00−113.75) 18.75 (0.00−150) 0.00 (0.00−150) H = 0.613 0.736
Mood stabilizer (yes/no) 29.0 (29.0) 5 (20.0) 15 (30.0) 9 (36.0) χ2 (2,98) = 1.603 0.449

Values are presented as number (%) or median (Q1−Q3).

HAMD-17, 17-item Hamilton Depression Rating Scale; BDI, Beck Depression Inventory; YMRS, Young Mania Rating Scale; BO, BDI relative-overrating; BC, BDI relatively concordant; BU, BDI relative-underrating.

Significant pvalues are shown in the asterisk (p < 0.05).

Comparison of questionnaire scores (CTQ-6, SRS-A, WCCL) among BDI-based groups

Measures BO group (n = 25) BC group (n = 50) BU group (n = 25) Statistical comparison Adjustment significant pairwise comparisons

H-statistic pvalue
CTQ-6
Physical abuse 2.00 (2−3) 2.00 (2−2) 2.00 (2−2) 4.059 0.131
Emotional abuse 5.00 (3−8) 2.50 (2−5) 2.00 (2−3) 12.591 0.002* BO > BC, p = 0.017*
BO > BU, p = 0.002*
Emotional neglect 6.00 (4−8) 5.00 (3.75−6) 4.00 (4−6) 3.864 0.145
CTQ-6 total score 12.00 (9−20) 11.00 (7.75−13.5) 9.00 (8−11.25) 7.99 0.018* BO > BU, p = 0.015*
SRS-A
Social awareness 8.00 (7−10) 7.00 (5−9) 6.00 (4.75−9.25) 5.741 0.057
Social cognition 17.00 (14−21) 11.00 (7.00−15.25) 11.00 (3.75−15) 15.487 < 0.001* BO > BC, p = 0.001*
BO > BU, p = 0.001*
Social communication 32.00 (23−38) 20.50 (16−28) 14.50 (9.75−26) 18.748 < 0.001* BO > BC, p = 0.002*
BO > BU, p < 0.001*
Social motivation 20.00 (17−25) 15.50 (10−19) 11.50 (6.75−18.25) 23.636 < 0.001* BO > BC, p = 0.001*
BO > BU, p < 0.001*
Autistic mannerisms 18.00 (14−22) 9.50 (6−14) 5.50 (2.75−12) 23.018 < 0.001* BO > BC, p = 0.001*
BO > BU, p < 0.001*
SRS-A total score 102.00 (77−109) 63.50 (50.5−78.25) 46.50 (27.0−86.0) 23.861 < 0.001* BO > BC, p < 0.001*
BO > BU, p < 0.001*
WCCL
Problem-solving 1.50 (1.29−2.14) 1.64 (1.43−2.00) 1.93 (1.60−2.38) 5.519 0.063
Positive cognitive coping 1.10 (0.7−1.5) 1.20 (0.9−1.73) 1.45 (0.85−2.03) 2.278 0.320
Social support 1.67 (0.83−2.5) 1.67 (1.0−2.33) 1.75 (1.33−2.33) 0.395 0.821
Self-blame 2.75 (2.25−3.0) 2.00 (1.68−2.75) 1.63 (1.00−2.30) 12.353 0.002* BO > BC, p = 0.023*
BO > BU, p = 0.002*
Wishful thinking 1.50 (0.83−2.17) 1.50 (1.17−2.00) 1.00 (0.167−1.88) 6.972 0.031* BC > BU, p = 0.039*
Escape-avoidance 1.43 (0.86−1.71) 1.29 (1.00−1.57) 0.93 (0.68−1.30) 8.285 0.016* BC > BU, p = 0.014*

Values are presented as median (Q1−Q3).

CTQ-6, Childhood Trauma Questionnaire; SRS-A, Social Responsiveness Scale; WCCL, Way of Coping Checklist; BDI, Beck Depression Inventory; BO, BDI relative-overrating; BC, BDI relatively concordant; BU, BDI relative-underrating.

Significant pvalues are shown in the asterisk (p < 0.05). Pairwise multiple comparisons were conducted with Bonferroni correction.

References
  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C.:American Psychiatric Association;2013.
    CrossRef
  2. Wang HR, Bahk WM, Yoon BH, Kim MD, Jung YE, Min KJ, et al. The influence of current mood states on screening accuracy of the mood disorder questionnaire. Clin Psychopharmacol Neurosci 2020;18:25-31.
    Pubmed KoreaMed CrossRef
  3. Yasui-Furukori N, Adachi N, Kubota Y, Azekawa T, Goto E, Edagawa K, et al. Factors associated with doses of mood stabilizers in real-world outpatients with bipolar disorder. Clin Psycho-pharmacol Neurosci 2020;18:599-606.
    Pubmed KoreaMed CrossRef
  4. Greden JF. The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 2001;62 Suppl 22:5-9.
    Pubmed
  5. Hayes JF, Miles J, Walters K, King M, Osborn DP. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand 2015;131:417-425.
    Pubmed KoreaMed CrossRef
  6. Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999;156:1000-1006.
    Pubmed CrossRef
  7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
    Pubmed KoreaMed CrossRef
  8. Hamilton M. Comparative value of rating scales. Br J Clin Pharmacol 1976;3(1 Suppl 1):58-60.
    Pubmed KoreaMed CrossRef
  9. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
    Pubmed CrossRef
  10. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-583. Erratum in: Biol Psychiatry 2003;54:585.
    Pubmed CrossRef
  11. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
    Pubmed CrossRef
  12. Lewis CC, Boyd M, Puspitasari A, Navarro E, Howard J, Kassab H, et al. Implementing measurement-based care in behavioral health: a review. JAMA Psychiatry 2019;76:324-335.
    Pubmed KoreaMed CrossRef
  13. Möller HJ. Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales. Pharmacopsychiatry 1991;24:71-75.
    Pubmed CrossRef
  14. IsHak WW, Mirocha J, Pi S, Tobia G, Becker B, Peselow ED, et al. Patient-reported outcomes before and after treatment of major depressive disorder. Dialogues Clin Neurosci 2014;16:171-183.
    Pubmed KoreaMed CrossRef
  15. Davis K, Schoenbaum SC, Audet AM. A 2020 vision of patient-centered primary care. J Gen Intern Med 2005;20:953-957.
    Pubmed KoreaMed CrossRef
  16. Domken M, Scott J, Kelly P. What factors predict discrepancies between self and observer ratings of depression? J Affect Disord 1994;31:253-259.
    Pubmed CrossRef
  17. Bailey J, Coppen A. A comparison between the Hamilton Rating Scale and the Beck Inventory in the measurement of depression. Br J Psychiatry 1976;128:486-489.
    Pubmed CrossRef
  18. Rush AJ, Hiser W, Giles DE. A comparison of self-reported versus clinician-related symptoms in depression. J Clin Psychiatry 1987;48:246-248.
    Pubmed
  19. Enns MW, Larsen DK, Cox BJ. Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affect Disord 2000;60:33-41.
    Pubmed CrossRef
  20. Schneibel R, Brakemeier EL, Wilbertz G, Dykierek P, Zobel I, Schramm E. Sensitivity to detect change and the correlation of clinical factors with the Hamilton Depression Rating Scale and the Beck Depression Inventory in depressed inpatients. Psychiatry Res 2012;198:62-67.
    Pubmed CrossRef
  21. Corruble E, Legrand JM, Zvenigorowski H, Duret C, Guelfi JD. Concordance between self-report and clinician's assessment of depression. J Psychiatr Res 1999;33:457-465.
    Pubmed CrossRef
  22. Duberstein PR, Heisel MJ. Personality traits and the reporting of affective disorder symptoms in depressed patients. J Affect Disord 2007;103:165-171.
    Pubmed CrossRef
  23. Suzuki M, Dallaspezia S, Locatelli C, Uchiyama M, Colombo C, Benedetti F. Discrepancy between subjective and objective severity as a predictor of response to chronotherapeutics in bipolar depression. J Affect Disord 2016;204:48-53.
    Pubmed CrossRef
  24. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33; quiz 34-57.
    Pubmed
  25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association;1994.
  26. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435.
    Pubmed CrossRef
  27. Hayashi K, Takimoto T. An examination of Beck depression inventory (1978) and an analysis of relation between depressive tendencies and grade of self‐efficacy (cultural and social science). Mem Shiraume Gakuen Coll 1991;27:43-52.
  28. Kuttler H, Schwendemann H, Bitzer EM. Familial risk and protective factors in alcohol intoxicated adolescents:. psychometric evaluation of the family domain of the Communities That Care Youth Survey (CTC) and a new short version of the Childhood Trauma Questionnaire (CTQ) BMC Pediatr 2015;15:191.
    Pubmed KoreaMed CrossRef
  29. Constantino JN, Gruber CP. Social Responsiveness Scale (SRS). Western Psychological Services;2005.
  30. Constantino JN, Gruber CP. Social Responsiveness Scale second edition (SRS-2). Western Psychological Services;2012.
  31. Takei R, Matsuo J, Takahashi H, Uchiyama T, Kunugi H, Kamio Y. Verification of the utility of the social responsiveness scale for adults in non-clinical and clinical adult populations in Japan. BMC Psychiatry 2014;14:302.
    Pubmed KoreaMed CrossRef
  32. Folkman S, Lazarus RS. If it changes it must be a process: study of emotion and coping during three stages of a college examination. J Pers Soc Psychol 1985;48:150-170.
    Pubmed CrossRef
  33. Nakano K. Coping strategies and psychological symptoms in a Japanese sample. J Clin Psychol 1991;47:346-350.
    Pubmed CrossRef
  34. Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, et al. Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder. J Psychiatr Res 2011;45:96-103.
    Pubmed KoreaMed CrossRef
  35. Ballantine JP, Jerbert AR. Distance from a line, or plane, to a poin. Am Math Mon 1952;59:242-243.
    CrossRef
  36. Dunn OJ. Multiple comparisons using rank sums. Technometrics 1964;6:241-252.
    CrossRef
  37. Carter JD, Frampton CM, Mulder RT, Luty SE, Joyce PR. The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression. J Affect Disord 2010;124:202-206.
    Pubmed CrossRef
  38. Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, et al. Correlation between patient and clinician assessments of depression severity in the PREVENT study. Psychiatry Res 2010;177:177-183.
    Pubmed KoreaMed CrossRef
  39. Christ C, de Waal MM, Dekker JJM, van Kuijk I, van Schaik DJF, Kikkert MJ, et al. Linking childhood emotional abuse and depressive symptoms: the role of emotion dysregulation and interpersonal problems. PLoS One 2019;14:e0211882.
    Pubmed KoreaMed CrossRef
  40. Nelson J, Klumparendt A, Doebler P, Ehring T. Childhood maltreatment and characteristics of adult depression: meta- analysis. Br J Psychiatry 2017;210:96-104.
    Pubmed CrossRef
  41. Shapero BG, Black SK, Liu RT, Klugman J, Bender RE, Abramson LY, et al. Stressful life events and depression symptoms: the effect of childhood emotional abuse on stress reactivity. J Clin Psychol 2014;70:209-223.
    Pubmed KoreaMed CrossRef
  42. Matsuo J, Kamio Y, Takahashi H, Ota M, Teraishi T, Hori H, et al. Autistic-like traits in adult patients with mood disorders and schizophrenia. PLoS One 2015;10:e0122711.
    Pubmed KoreaMed CrossRef
  43. Hori H, Teraishi T, Ota M, Hattori K, Matsuo J, Kinoshita Y, et al. Psychological coping in depressed outpatients: association with cortisol response to the combined dexamethasone/CRH test. J Affect Disord 2014;152-154:441-447.
    Pubmed CrossRef
  44. Uehara T, Sakado K, Sakado M, Sato T, Someya T. Relation-ship between stress coping and personality in patients with major depressive disorder. Psychother Psychosom 1999;68:26-30.
    Pubmed CrossRef


This Article

Close ✕


Cited By Articles

Author ORCID Information

Funding Information

Services
Social Network Service

e-submission

Archives